Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
Clinical trial NCT07268612 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07268612
- Sponsor
- Emergent BioSolutions
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2035-11-01
- Primary completion
- 2036-11-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.